Chromadex external research program (cerp™) achieves 200th material transfer agreement for niagen® (nicotinamide riboside) research

Chromadex corp. (nasdaq:cdxc) today announced the company has signed its 200th material transfer agreement (mta) through its global chromadex external

CZR Ratings Summary

CZR Quant Ranking